Athos Therapeutics Inc
2 clinical trials · Sponsor
◉ Watch Athos Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) (NCT07513181) | Athos Therapeutics Inc | 2026-06-01 |
| Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects (NCT05807971) | Athos Therapeutics Inc | 2023-04-06 |
Track Athos Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.